Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer. [electronic resource]
Producer: 20150730Description: 10434-45 p. digitalISSN:- 1949-2553
- Antibodies, Monoclonal -- pharmacology
- Apoptosis -- drug effects
- Carboplatin -- pharmacology
- Carcinoma, Non-Small-Cell Lung -- immunology
- Cell Line, Tumor
- Down-Regulation
- Drug Resistance -- drug effects
- Drug Synergism
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Lung Neoplasms -- immunology
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase 3 -- metabolism
- Molecular Targeted Therapy
- Oncogene Protein v-akt -- metabolism
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins -- genetics
- RNA, Small Interfering -- genetics
- Receptor Protein-Tyrosine Kinases -- genetics
- STAT6 Transcription Factor -- metabolism
- Signal Transduction -- drug effects
- Tumor Stem Cell Assay
- c-Mer Tyrosine Kinase
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.